CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance-A preliminary research
- PMID: 29791512
- PMCID: PMC5965889
- DOI: 10.1371/journal.pone.0197663
CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance-A preliminary research
Abstract
Background: Increased hepatic insulin clearance (HIC) is important in the pathophysiology of type 2 diabetes mellitus (T2DM). The aim of this study is to analyze an effective insulin resistance (IR) index that is minimally affected by HIC.
Methods: Our study involved 20 participants with T2DM and 21 healthy participants without diabetes (Non-DM). Participants underwent a meal tolerance test from which plasma glucose, insulin and serum C-peptide immunoreactivity (CPR) were measured, and HOMA-IR and HIC were calculated. Participants then underwent a hyperinsulinemic-euglycemic clamp from which the glucose disposal rate (GDR) was measured.
Results: The index CPR-IR = 20/(fasting CPR × fasting plasma glucose) was correlated more strongly with GDR, than was HOMA-IR, and CPR-IR could be used to estimate GDR. In T2DM participants with HIC below the median, HOMA-IR and CPR-IR were equally well correlated with GDR. In T2DM with high HIC, CPR-IR correlated with GDR while HOMA-IR did not. In Non-DM, CPR-IR and HOMA-IR were equally well correlated with GDR regardless of HIC. The mean HIC value in T2DM was significantly higher than that of Non-DM.
Conclusions: CPR-IR could be a simple and effective index of insulin resistance for patients with type 2 diabetes that is minimally affected by HIC.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Fasting hepatic insulin clearance reflects postprandial hepatic insulin clearance: a brief report.Diabetol Metab Syndr. 2023 Dec 20;15(1):261. doi: 10.1186/s13098-023-01241-4. Diabetol Metab Syndr. 2023. PMID: 38115089 Free PMC article.
-
20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.Cardiovasc Diabetol. 2013 Jan 22;12:21. doi: 10.1186/1475-2840-12-21. Cardiovasc Diabetol. 2013. PMID: 23339473 Free PMC article.
-
Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study.PLoS One. 2017 Jun 27;12(6):e0179737. doi: 10.1371/journal.pone.0179737. eCollection 2017. PLoS One. 2017. PMID: 28654680 Free PMC article.
-
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report.BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001149. doi: 10.1136/bmjdrc-2019-001149. BMJ Open Diabetes Res Care. 2020. PMID: 32354719 Free PMC article.
-
The Measurement of Insulin Clearance.Diabetes Care. 2020 Sep;43(9):2296-2302. doi: 10.2337/dc20-0750. Diabetes Care. 2020. PMID: 32910777 Free PMC article. Review.
Cited by
-
Fasting hepatic insulin clearance reflects postprandial hepatic insulin clearance: a brief report.Diabetol Metab Syndr. 2023 Dec 20;15(1):261. doi: 10.1186/s13098-023-01241-4. Diabetol Metab Syndr. 2023. PMID: 38115089 Free PMC article.
-
Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes.Diabetes Ther. 2021 Mar;12(3):827-842. doi: 10.1007/s13300-021-01008-y. Epub 2021 Feb 13. Diabetes Ther. 2021. PMID: 33586119 Free PMC article.
-
Associations of gestational cardiovascular health with pregnancy outcomes: the Hyperglycemia and Adverse Pregnancy Outcome study.Am J Obstet Gynecol. 2021 Feb;224(2):210.e1-210.e17. doi: 10.1016/j.ajog.2020.07.053. Epub 2020 Aug 5. Am J Obstet Gynecol. 2021. PMID: 32768430 Free PMC article.
-
Circulating levels of selected adipokines in women with gestational diabetes and type 2 diabetes.J Appl Biomed. 2020 Aug;18(2-3):54-60. doi: 10.32725/jab.2020.007. Epub 2020 May 18. J Appl Biomed. 2020. PMID: 34907726
-
Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study.Diabetes Ther. 2019 Oct;10(5):1835-1846. doi: 10.1007/s13300-019-0666-7. Epub 2019 Jul 12. Diabetes Ther. 2019. PMID: 31300948 Free PMC article.
References
-
- DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667–687. - PubMed
-
- DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: 214–223. - PubMed
-
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419. - PubMed
-
- Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism 2005; 54: 206–211. doi: 10.1016/j.metabol.2004.08.014 - DOI - PubMed
-
- Kadowaki T, Miyake Y, Kajinuma H. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
